Advertisement
Advertisement
GKOS
Glaukos Corporation
186.63
USDSponsored
+4.63
+2.54%
Aug 12, 16:00 UTC -4
Closed
After-Market
186.53
-0.10
-0.06%
GKOS Earnings Reports
Positive Surprise Ratio
GKOS beat 30 of 43 last estimates.
70%
Next Report
Date of Next Report
Oct 27, 2026
Estimate for Q3 26 (Revenue/ EPS)
$171.02M
/-$0.10
Implied change from Q2 26 (Revenue/ EPS)
-7.86%
/-28.57%
Implied change from Q3 25 (Revenue/ EPS)
+28.07%
/-37.50%
Glaukos Corporation earnings per share and revenue
On Jul 29, 2026, GKOS reported earnings of -0.14 USD per share (EPS) for Q2 26, beating the estimate of -0.21 USD, resulting in a 34.85% surprise. Revenue reached 185.61 million, compared to an expected 153.94 million, with a 20.58% difference. The market reacted with a +4.24% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.10 USD, with revenue projected to reach 171.02 million USD, implying an decrease of -28.57% EPS, and decrease of -7.86% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tactile Systems Technology, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.14
Actual
$0.34
Surprise
+131.45%
Mesa Laboratories Inc
Report Date
Aug 10, 2026 For Q1 27
Estimate
$0.03
Actual
$2.61
Surprise
+8,429.41%
Mobia Medical, Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.65
Actual
-$0.88
Surprise
-33.41%
908 Devices Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.17
Actual
-$0.11
Surprise
+36.56%
Neuronetics, Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.12
Actual
-$0.05
Surprise
+60.00%
Stereotaxis, Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Xtant Medical Holdings, Inc.
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.07
Surprise
-243.14%
Spectral AI, Inc. Class A Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.13
Surprise
+5.59%
DarioHealth Corp. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$1.23
Actual
-$0.56
Surprise
+54.01%
QT Imaging Holdings, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.22
Actual
-$0.19
Surprise
+15.06%
FAQ
What were Glaukos Corporation's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Glaukos Corporation reported EPS of -$0.14, beating estimates by 34.85%, and revenue of $185.61M, 20.58% above expectations.
How did the market react to Glaukos Corporation's Q2 2026 earnings?
The stock price moved up 4.24%, changed from $161.66 before the earnings release to $168.52 the day after.
When is Glaukos Corporation expected to report next?
The next earning report is scheduled for Oct 27, 2026.
What are the forecasts for Glaukos Corporation's next earnings report?
Based on --
analysts, Glaukos Corporation is expected to report EPS of -$0.10 and revenue of $171.02M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement